Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 682

1.

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J.

Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9.

2.

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW.

Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3.

3.

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.

Jain AB, Kashyap R, Rakela J, Starzl TE, Fung JJ.

Liver Transpl Surg. 1999 Mar;5(2):144-50.

4.

The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.

Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.

Transplantation. 2003 Apr 15;75(7):1020-5.

PMID:
12698091
6.

Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.

Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J.

Transplantation. 2000 Jun 27;69(12):2573-80.

PMID:
10910279
7.

Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.

Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.

Pediatr Transplant. 1999 Feb;3(1):22-6.

PMID:
10359027
8.

Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.

Jain A, Marcos A, Reyes J, Mazariagos G, Kashyap R, Eghtesad B, Marsh W, Fontas P, De Vera M, Costa G, Patel K, Gadomski M, Starzl T, Fung J.

Transplant Proc. 2005 Mar;37(2):1207-10.

PMID:
15848671
9.

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.

Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.

Transpl Int. 2001 Dec;14(6):420-8.

10.

Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.

Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, Mazariegos GV.

Transplantation. 2002 Dec 27;74(12):1721-4.

PMID:
12499888
11.

Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year.

Caccamo L, Colledan M, Rossi G, Gridelli B, Maggi U, Vannelli A, Damilano I, Lucianetti A, Paone G, Gatti S, Reggiani P, Fassati LR.

Transpl Int. 1998;11 Suppl 1:S212-20.

12.

Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.

McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.

J Pediatr Surg. 1997 May;32(5):688-90.

PMID:
9165452
13.

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.

Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M; European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.

Nephrol Dial Transplant. 2005 May;20(5):968-73. Epub 2005 Mar 1.

PMID:
15741208
14.

Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus.

Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J.

Transplantation. 2000 Nov 15;70(9):1335-42.

PMID:
11087149
15.

Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.

Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.

Pediatr Transplant. 2006 Dec;10(8):938-42.

PMID:
17096762
16.

Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.

Cacciarelli TV, Green M, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Reyes J.

Transplantation. 1998 Oct 27;66(8):1047-52.

PMID:
9808490
17.

Tacrolimus: a further update of its use in the management of organ transplantation.

Scott LJ, McKeage K, Keam SJ, Plosker GL.

Drugs. 2003;63(12):1247-97. Review.

PMID:
12790696
18.

Cyclosporin versus tacrolimus for liver transplanted patients.

Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005161. Review.

PMID:
17054241
19.

Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.

Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung J, Reyes J.

Transplantation. 2000 Aug 27;70(4):617-25.

20.

Pediatric renal transplantation under tacrolimus-based immunosuppression.

Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Gilboa N, Gritsch HA, Irish W, McCauley J, Fung JJ, Hakala TR, Simmons RL, Starzl TE.

Transplantation. 1999 Jan 27;67(2):299-303.

Supplemental Content

Support Center